CEO, Steve Edgett, and Chief Scientific Officer, Jeremy Bridge-Cook sit down with GenomeWeb to share some groundbreaking developments at Genomadix.

Check out the article below:

Genomadix Eyes Expanded PGx Applications, Outlicensing for Rapid PCR System | GenomeWeb